J & J and Merck Ebola Vaccines Produce Lasting Antibodies in Children and Adults: Studies J & J and Merck Ebola Vaccines Produce Lasting Antibodies in Children and Adults: Studies
Ebola vaccines developed by Johnson& Johnson and Merck produced virus-fighting antibodies and appear to be safe in children and adults, according to data from two studies published on Wednesday.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
More News: Children | Ebola | Ebola Vaccine | Health | Infectious Diseases | Merck | Study | Vaccines